CHARM Therapeutics Company

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Industry: AI, Early Drug Development
Headquarters: London, England, United Kingdom
Founded Date: 2021-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 6
Total Funding: 50000000
Last Funding Date: 2022-06-09
Last Funding Type: Series A

Visit Website
laksh@charmtx.com
Register and Claim Ownership